Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction

Completed · Phase 2 · Has a placebo group

Conditions studied: Acute Myocardial Infarction

In brief

The purpose of this study is to determine the efficacy of intravenous human beta natriuretic peptide (BNP, Nesiritide) as compared to placebo to prevent adverse post acute myocardial infarction left ventricular remodeling.

Key facts

Study ID
NCT00573144
Run by
Mayo Clinic
People needed
59
Starts
2006-09-01
Expected to finish
2013-04-01
Last updated by the study team
2014-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.